From New York Post · · 1m 50s
Pancreatic Cancer Study Finds Racial Differences in Tumor Cells
Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments.
In brief
Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments. Pancreatic tumors from Black patients show fewer common cancer cells and more immune cell clusters, potentially improving treatment personalization. Originally reported by…
Study Finds Racial Differences in Pancreatic Tumors

A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently, potentially leading to more personalized treatments.
22 Tumors from Diverse Patients Analyzed

Researchers examined 22 pancreatic tumors from patients of different racial backgrounds across the U.S., looking for differences in cancer cells and how the immune system responds to them.
Black Patients Show Fewer Common Cancer Cells

Tumors from Black patients had fewer of the most common type of pancreatic cancer cells and more cells with a mix of different characteristics, the researchers found.
More Immune Cells in Black Patients

Additionally, tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells.
Immunotherapy Challenges in Pancreatic Cancer

Dr. Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, said that using immunotherapy to help the immune system attack the disease has been particularly challenging in pancreatic cancer.
“That’s been very difficult to do in pancreatic cancer because the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body”
Study Highlights Racial Inclusion in Research
The findings highlight the importance of including patients from different backgrounds in cancer research, according to lead study author Nina Steele, Ph.D., an assistant professor in UC’s College of Medicine.
“This study shows that ignoring diverse ancestry in medical research leaves blind spots in the search for a cure”
Potential for Personalized Treatments
Wadlow noted that pancreatic cancers can share major DNA mutations but can differ considerably in how their cells behave and interact with nearby immune cells and surrounding tissue.
Limitations and Future Steps

Researchers have not established how the intermediate tumor cells affect survival or whether they respond differently to standard chemotherapy, Steele said.
The bottom line
Pancreatic tumors from Black patients show fewer common cancer cells and more immune cell clusters, potentially improving treatment personalization.
Read the TL;DR — this story on one card.




